I get it now.
It's being artificially inflated.
Look at the buy sell spread. Even last week there was very little interest but shares kept being bought at the higher end.
The company is going to need to raise cash if it wants to buy more of jaxta.
By artificially sending the SP higher, the company can:
1. Convince Share Holders that the investment is in their best interest citing the rising SP since the announcements
2. Raise capital by selling more shares at a higher price.
I'm convinced this is what is going on. The motive is there and this explains why shares are being bought whilst the buy/sell spread is so large.
But who's buying the shares at these levels? My guess is the people who have the most to gain and who are not already a significant holder (otherwise it would show up in a significant holding modification announcement).
FYI, just because i'm convinced, doesn't make it true
- Forums
- ASX - By Stock
- Ann: Mobilarm enters into investment in Jaxsta Enterprises-MBO.AX
I get it now. It's being artificially inflated. Look at the buy...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VNL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.54M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 9.8¢ | $56.07K | 556.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 26920 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 33999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19420 | 0.100 |
1 | 959 | 0.099 |
3 | 113172 | 0.098 |
4 | 115327 | 0.095 |
1 | 15000 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 33999 | 2 |
0.110 | 100000 | 1 |
0.115 | 166666 | 2 |
0.120 | 90580 | 2 |
0.125 | 5000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
VNL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online